Part of the difficulty with being a physician that treats medical obesity is having to come up with options that we know are not superior to what we want to give and having to give inferior options because the limiting factor is insurance coverage, Shah said
These are usually temporary but should be reported to your doctor if they are severe or persistent
References: Ozempic list price explanation, Novo Nordisk (2024) Patient Assistance Program (PAP), Novo Nordisk (2024) Wegovy list price explanation, Novo Nordisk (2024) Rybelsus list price explanation, Novo Nordisk (2024) Semaglutide market report, Grand View Research (2024) FDA clarifies policies as GLP-1 supply stabilizes, FDA (2024) Compounded semaglutide: how to better ensure its safety, Medscape (2024) Illicit compounding position, Novo Nordisk (2025)
Insulin Resistance Support blood sugar regulation and improve metabolic function
Mounjaro is administered by weekly subcutaneous injections, and the dose can be adjusted according to tolerability
Can I combine medical weight loss with other treatments at Arch Medical Group in St